Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...
The U.S. Meals and Drug Administration (FDA) has accepted PD-L1 IHC 22C3 pharmDx, Code SK006, as a companion diagnostic to assist establish sufferers with epithelial...
In an interview for CURE Educated Affected person® Updates, Drs. Alexandra Miller, Daniel Orringer and Jonathan Yang mentioned how understanding analysis, biomarker...
Dr. Graeme M. Rosenberg, a thoracic surgeon specializing in airway intervention and reconstruction, and Dr. Jorge J. Nieva, an affiliate professor of...
